- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04783883
Electrical Vestibular Nerve Stimulation (VeNS): A Follow-up Assessment of Long-term Usage
January 15, 2024 updated by: Neurovalens Ltd.
Electrical Vestibular Nerve Stimulation (VeNS): A Follow-up Safety Assessment of Long-Term Usage
A follow-up assessment study of the long-term safety of vestibular electrical stimulation as delivered by the Vestal DM Device.
Study Overview
Detailed Description
A retrospective, open-label, follow-up study assessing the long-term safety and efficacy of vestibular electrical stimulation as delivered by the Vestal DM Device.
Study Type
Observational
Enrollment (Actual)
25
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Belfast, United Kingdom, BT2 8DN
- Neurovalens Ltd., 7 James St. South
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Vestal DM device users from any country.
Description
Inclusion Criteria:
- Vestal DM user (more than 6 months)
Exclusion Criteria:
- Vestal DM device user (less than 6 months)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Assessment of hearing function as reported by formal audiometry testing
Time Frame: Baseline
|
Formal audiometry testing to be conducted using the AMTAS Flex Device
|
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Frequency of device related adverse events
Time Frame: Baseline
|
Baseline
|
|
Inspection of the skin behind the ears (mastoid area)
Time Frame: Baseline
|
Photographic inspection of the skin behind the ears to confirm no skin irritation has been caused at the mastoid area where the electrode pads are placed
|
Baseline
|
Otoscope examination of the inside of both ear canals and tympanic membranes
Time Frame: Baseline
|
Photographs to be taken of both ear canals and both tympanic membranes using the Awelor Wireless Smart Otoscope (Model Number: T1).
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 4, 2021
Primary Completion (Actual)
July 5, 2021
Study Completion (Actual)
July 23, 2021
Study Registration Dates
First Submitted
March 3, 2021
First Submitted That Met QC Criteria
March 3, 2021
First Posted (Actual)
March 5, 2021
Study Record Updates
Last Update Posted (Actual)
January 17, 2024
Last Update Submitted That Met QC Criteria
January 15, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- RWDMES01
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Safety Issues
-
Chulalongkorn UniversityNot yet recruiting
-
IC-MedTech CorporationRecruiting
-
Showa Inan General HospitalRecruiting
-
Asmaa Elwan Mohammed HassanCompleted
-
Hadassah Medical OrganizationGals Bio Ltd.Withdrawn
-
Federico II UniversityCompleted
-
Institute of Nuclear Energy Research, TaiwanCompleted
-
University of JordanCompleted
-
Hospital Universitario La FeSENSAR (Sistema español de notificación en seguridad en anestesia y reanimación)Completed
Clinical Trials on Vestal DM
-
Neurovalens Ltd.University College Dublin; Clinical Trial Mentors; CS LifescienceActive, not recruitingType 2 DiabetesUnited States, Ireland
-
Neurovalens Ltd.University College Dublin; Exploristics Ltd; Compliance Solutions Ltd.Completed
-
Neurovalens Ltd.University of California, San Diego; University of Ulster; Compliance Solutions... and other collaboratorsCompletedObesityUnited States, United Kingdom
-
Neurovalens Ltd.RD Gardi Medical CollegeCompleted
-
Neurovalens Ltd.University College Dublin; Exploristics Ltd; Compliance Solutions Ltd.CompletedObesity | Overweight | Metabolic Syndrome | Overweight and Obesity | Overweight or ObesityIreland
-
Medical College of WisconsinRecruiting
-
Desentum OyCompletedBirch Pollen AllergyFinland
-
Sun Yat-sen UniversityRecruitingDeep Learning | 3D-reconstruction | Patient Privacy | Digital MedicineChina
-
National University, SingaporeTsao Foundation SingaporeActive, not recruiting
-
Emory UniversityNational Institute of Nursing Research (NINR); Atlanta VA Medical Center; Atlanta...CompletedHeart Failure | Diabetes MellitusUnited States